Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TGFP (also referred to as TGF) is an herbal formula based on the traditional Chinese medicine **Hu-Qian Wan** (Hidden Tiger Pill), which is being developed by **China Medical University Hospital** for the treatment of **knee osteoarthritis**. The formula is a multi-ingredient botanical product traditionally used to nourish kidney yin and strengthen bones and tendons. In clinical studies, TGFP is being evaluated for its ability to reduce pain and improve joint function by modulating biochemical markers associated with cartilage degradation and inflammation, such as interleukin-1 (IL-1), interleukin-6 (IL-6), matrix metalloproteinases (MMP-3, MMP-13), and ADAMTS-4. The formula typically contains ingredients such as Phellodendri Chinensis Cortex, Anemarrhenae Rhizoma, and Rehmanniae Radix Praeparata.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TGFP (China Medical University Hospital).